Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,924 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Identification of a Novel Allosteric Inhibitory Site on Tryptophan Hydroxylase 1 Enabling Unprecedented Selectivity Over all Related Hydroxylases.
Petrassi M, Barber R, Be C, Beach S, Cox B, D'Souza AM, Duggan N, Hussey M, Fox R, Hunt P, Jarai G, Kosaka T, Oakley P, Patel V, Press N, Rowlands D, Scheufler C, Schmidt O, Srinivas H, Turner M, Turner R, Westwick J, Wolfreys A, Pathan N, Watson S, Thomas M. Petrassi M, et al. Among authors: turner m, turner r. Front Pharmacol. 2017 May 5;8:240. doi: 10.3389/fphar.2017.00240. eCollection 2017. Front Pharmacol. 2017. PMID: 28529483 Free PMC article.
Synthesis and evaluation of two series of 4'-aza-carbocyclic nucleosides as adenosine A2A receptor agonists.
Beattie D, Brearley A, Brown Z, Charlton SJ, Cox B, Fairhurst RA, Fozard JR, Gedeck P, Kirkham P, Meja K, Nanson L, Neef J, Oakman H, Spooner G, Taylor RJ, Turner RJ, West R, Woodward H. Beattie D, et al. Among authors: turner rj. Bioorg Med Chem Lett. 2010 Feb 1;20(3):1219-24. doi: 10.1016/j.bmcl.2009.11.131. Epub 2009 Dec 1. Bioorg Med Chem Lett. 2010. PMID: 20031406
In vitro and in vivo pharmacological characterization of 5-[(R)-2-(5,6-diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-1H-quinolin-2-one (indacaterol), a novel inhaled beta(2) adrenoceptor agonist with a 24-h duration of action.
Battram C, Charlton SJ, Cuenoud B, Dowling MR, Fairhurst RA, Farr D, Fozard JR, Leighton-Davies JR, Lewis CA, McEvoy L, Turner RJ, Trifilieff A. Battram C, et al. Among authors: turner rj. J Pharmacol Exp Ther. 2006 May;317(2):762-70. doi: 10.1124/jpet.105.098251. Epub 2006 Jan 24. J Pharmacol Exp Ther. 2006. PMID: 16434564
The Adelaide Score: prospective implementation of an artificial intelligence system to improve hospital and cost efficiency.
Kovoor JG, Stretton B, Gupta AK, Beath A, Jacob MO, Kefalianos JM, Carmichael GJ, Zaka A, O'Callaghan G, Satheakeerthy S, Booth A, Delloso T, Hugh TJ, Chan WO, Maddern GJ, Balan-Vnuk E, Cusack M, Gilbert T, Maddison J, Bacchi S; Adelaide Score Advisory Group. Kovoor JG, et al. ANZ J Surg. 2025 Jan 3. doi: 10.1111/ans.19383. Online ahead of print. ANZ J Surg. 2025. PMID: 39754371
Robust, fully-automated assessment of cerebral perivascular spaces and white matter lesions: a multicentre MRI longitudinal study of their evolution and association with risk of dementia and accelerated brain atrophy.
Barisano G, Iv M, Choupan J, Hayden-Gephart M; Alzheimer’s Disease Neuroimaging Initiative. Barisano G, et al. EBioMedicine. 2024 Dec 24;111:105523. doi: 10.1016/j.ebiom.2024.105523. Online ahead of print. EBioMedicine. 2024. PMID: 39721217 Free article.
Longitudinal cognitive performance of participants with sporadic early onset Alzheimer's disease from LEADS.
Hammers DB, Eloyan A, Taurone A, Thangarajah M, Gao S, Beckett L, Polsinelli AJ, Kirby K, Dage JL, Nudelman K, Aisen P, Reman R, La Joie R, Lagarde J, Atri A, Clark D, Day GS, Duara R, Graff-Radford NR, Grant I, Honig LS, Johnson ECB, Jones DT, Masdeu JC, Mendez MF, Womack K, Musiek E, Onyike CU, Riddle M, Rogalski E, Salloway S, Sha SJ, Turner RS, Wingo TS, Wolk DA, Carrillo MC, Rabinovici GD, Dickerson BC, Apostolova LG; LEADS Consortium. Hammers DB, et al. Among authors: turner rs. Alzheimers Dement. 2024 Dec 23. doi: 10.1002/alz.14439. Online ahead of print. Alzheimers Dement. 2024. PMID: 39713873
Differences in baseline cognitive performance between participants with early-onset and late-onset Alzheimer's disease: Comparison of LEADS and ADNI.
Hammers DB, Eloyan A, Thangarajah M, Taurone A, Beckett L, Gao S, Polsinelli AJ, Kirby K, Dage JL, Nudelman K, Aisen P, Reman R, La Joie R, Lagarde J, Atri A, Clark D, Day GS, Duara R, Graff-Radford NR, Honig LS, Jones DT, Masdeu JC, Mendez MF, Womack K, Musiek E, Onyike CU, Riddle M, Grant I, Rogalski E, Johnson ECB, Salloway S, Sha SJ, Turner RS, Wingo TS, Wolk DA, Carrillo MC, Dickerson BC, Rabinovici GD, Apostolova LG; LEADS Consortium 1 for the Alzheimer's Disease Neuroimaging Initiative. Hammers DB, et al. Among authors: turner rs. Alzheimers Dement. 2024 Dec 23. doi: 10.1002/alz.14218. Online ahead of print. Alzheimers Dement. 2024. PMID: 39711228
A Meta-Analysis of Levofloxacin for Contacts of Multidrug-Resistant Tuberculosis.
Duong T, Brigden J, Simon Schaaf H, Garden F, Marais BJ, Anh Nguyen T, White IR, Gibb DM, Nhung NV, Martinson NA, Fairlie L, Martinez L, Layton C, Benedetti A, Marks GB, Turner RM, Seddon JA, Hesseling AC, Fox GJ. Duong T, et al. Among authors: turner rm. NEJM Evid. 2025 Jan;4(1):EVIDoa2400190. doi: 10.1056/EVIDoa2400190. Epub 2024 Dec 18. NEJM Evid. 2025. PMID: 39693627
4,924 results